Biopharma dealmaking activity remained strong in October, with total deal value reaching $31.86 billion, a 17% increase from $27.15 billion in September and ranking as the second-highest month in 2025 ...
Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...
The "Travel SIMs & eSIMs Market: 2025-2030" report has been added to ResearchAndMarkets.com's offering. Global Market Spending to Reach $8.7 Billion by 2030: Expanding 380% from $1.8 Billion in 2025.